Frank I. Lin
Molecular Imaging Program
The Center for Cancer Research
United States of America
Biography
Originally born in Taiwan, Dr. Lin immigrated with his family to the U.S. at a very young age and grew up in California. Dr. Lin's educational and professional pursuits has since taken him to many different parts of the United States. He completed his undergraduate work in biological sciences at Stanford University and has a Masters degree in medical informatics from the University of Utah. He went to medical school at the Medical College of Wisconsin and did his internal medicine and nuclear medicine residencies at Kaiser Permanente San Francisco and the University of California, Davis, respectively. After re-joining Stanford University for a PET/CT fellowship, Dr. Lin has worked at the NCI for the past 6 years in the Cancer Imaging Program in the Division of Cancer Treatment and Diagnosis. He was selected as a Lasker Clinical Research Scholar in 2016 and made the transition to intramural NCI as head of the newly created Targeted Radionuclide Therapy Section housed within the Molecular Imaging Program headed by Dr. Peter Choyke.
Research Interest
Cancer Biology, Clinical Research
Publications
-
PET/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Janssen I., Chen C., Millo C., Ling A., Taieb D., Lin FI, et al Eur J Nucl Med Mol Imaging. 43(10): 1784-91, 2016
-
Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy. Lin FI., Mena E., Lindenberg L., Adler S., Ton A., et al Eur J Nucl Med Mol Imaging. 44(3): 500-508, 2017
